Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo

NCT ID: NCT06010550

Last Updated: 2023-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to validate a machine learning model that stratifies the risk of stroke in patients who present to the emergency department with dizziness or vertigo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a cross-sectional, hospital-based study, with no randomization procedure. Over a 21-month period, approximately 600 subjects will be enrolled. The study will assess the risk of stroke in each patient using a machine-learning model. To detect ischemic or hemorrhagic stroke, each patient will undergo a non-contrast brain magnetic resonance imaging study. The predictive performance of the machine-learning model will be evaluated in terms of accuracy, precision, recall, F1 score, and area under the receiver operating characteristics curve.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dizziness Vertigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dizziness/vertigo

Patients aged 20 or above, presenting to the emergency department with dizziness or vertigo.

Magnetic resonance imaging

Intervention Type RADIATION

Brain magnetic resonance imaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic resonance imaging

Brain magnetic resonance imaging

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presenting to the emergency department with dizziness or vertigo
* Aged ≥ 20
* Dizziness or vertigo lasting for at least 1 hour and \< 7 days
* Persistent dizziness or vertigo at the time of the examination at the emergency department

Exclusion Criteria

* Having 5 or more prior episodes similar in quality, intensity, and duration to the current symptoms, with at least one episode more than a year prior and one within the past year
* Having frank stroke-like symptoms or signs, such as hemiparesis, facial asymmetry, dysarthria, dysphasia, ataxia, gaze palsy
* Consciousness disturbance, Glasgow coma scale \< 13
* Severe dementia
* Recent stroke within 3 months
* Dizziness or vertigo thought to be the result of head injury, hypotension, medication/drug intoxication, hypoglycemia, electrolyte imbalance, anemia, hepatic encephalopathy, hydrocephalus, etc
* Concomitant head or neck trauma
* Severe degenerative cervical spondylosis
* Having contraindications to magnetic resonance imaging examination
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Science and Technology Council

FED

Sponsor Role collaborator

Chiayi Christian Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sheng-Feng Sung, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Ditmanson Medical Foundation Chia-Yi Christian Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sheng-Feng Sung, MD, PhD

Role: CONTACT

886-5-2765041 ext. 7284

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB2023009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Automatic PredICtion of Edema After Stroke
NCT04057690 ACTIVE_NOT_RECRUITING
Stroke Imaging Package Study
NCT02485275 COMPLETED